Bipolar Disorder II
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Synaptic Imaging and Network Activity in Treatment Resistant Depression (NCT05870501) | King's College London | 2021-10-20 |
| Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder (NCT05025605) | BioXcel Therapeutics Inc | 2021-08-27 |
| Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK) (NCT04358900) | University of Illinois at Chicago | 2020-09-17 |
| Effect of Behavioral Intervention on Cannabinoid Receptors in BAD (NCT04168697) | Wayne State University | 2020-02-01 |
| A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode (NCT03692910) | Biogen | 2018-08-23 |
| PSYCHE (Personalised Monitoring SYstems for Care in Mental Health) (NCT01879982) | University Hospital, Strasbourg, France | 2013-05-01 |
| Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder (NCT03039842) | National Cheng-Kung University Hospital | 2013-01-01 |
Track Bipolar Disorder II automatically
Every clearance here is in the API, with alerts when new ones post.